top of page

Stefan Guldin


Project Lead

Dr Stefan Guldin is an Associate Professor at UCL and heads the Adaptive and Responsive Nanomaterials Group. Stefan’s research has led to the development of the technology to its current proof-of-concept status. 

Alaric Taylor


Innovation and design lead

Dr Alaric Taylor is CTO of Vesynta, possessing expertise in electrical engineering, physical chemistry and photonic systems, evidenced by a PhD, postdoctoral prize fellowship and MRes qualifications in respective subject matters.

Jugal Suthar


Programme Manager & 

Technology Transfer Lead

Dr Jugal Suthar has a background as a clinical pharmacist in NHS, big-pharma and community pharmacy settings, where he has witnessed integration of medical devices with patients at first hand.

Gareth Veal

Gareth Veal.jpg

Project Lead

Gareth Veal is Professor of cancer pharmacology, head of the NCCPG, an executive board member of the NUCC and a lead on early phase clinical trials in childhood cancers.

Pamela Kearns


Chief Clinical Advisor

Professor Pamela Kearns is Director of CRUK CTU, Director of the Institute of Cancer and Genomic Sciences at the University of Birmingham and Honorary Paediatric Oncologist at Birmingham Women and Children’s Hospital

Julia Chisholm


Clinical Oversight

Dr Julia Chisholm is Team Leader in Sarcoma Clinical Trials in Children and Young People at the Institute of Cancer Research. She is also a Consultant Paediatric Oncologist at The Royal Marsden, where she is Head of the Children and Young People’s Unit.

lisa headshot_edited.jpg

Lisa Pfaffenrath

Inclusion Lead, PPI

Lisa is the contact point between, researchers and stakeholder groups including children, parents and the general public. Lisa is a qualified teacher with experience in mainstream and special needs schools in the UK and Europe. Recently, Lisa completed a Master of Arts in Special and Inclusive Education from UCL Institute of Education.

Neil Ranasinghe_ 008.jpg

Neil Ranasinghe

PPI Rep (Parents)

Neil Ranasinghe is a parent of a child diagnosed with ALL and leads PORT, a parent/patient advocacy group that review clinical trial documentation and advise clinicians on aspects of clinical trials.


Deirdre Leyden

PPI Rep (Children)

Deirdre Leyden is PPI lead for research at GOSH BRC. She will assist in the organisation of4PPI sessions with the GOSH Young Persons Advisory Group for the project life cycle.

Melody Ni


Decision Analyst

Dr Melody Ni is a Senior Research Fellow in Department of Surgery & Cancer and serves as our Health Tech Assessment correspondent at the NIHR London IVD Cooperative.

Ami Bedi


Dev and Procedure Input

Ami Bedi is a Senior Research Nurse at GOSH who has experience in managing chemotherapy based clinical trials for the paediatric population.

Phillip Berry

Screenshot 2020-10-28 at 11.24.38.png

Bioanalytical oversight

Philip Berry is research associate based in the Newcastle University facility, with over 10 years of experience in analytical method development, assay validation and troubleshooting of hardware and software

Shelby Barnett


Research Associate

Dr Shelby Barnett is research associated based in the NCCPG facility with a background in Clinical Pharmacology

Neil Davidson


PPI Representative

Neil Davidson is The Medical Lead of the Young Person’s Advisory Group North England (YPAGne) and is a Consultant General Paediatrician at the Great North Children’s Hospital in Newcastle.

Pinkie Chambers


Pharmacology Oversight

Pinkie Chambers is a Lead Pharmacist in Applied Health Research Cancer Services, Joint Chair of the Chemotherapy Expert Reference group in North Central and North East London Cancer Collaborative and member of the UK Chemotherapy Board.

Stuart Ibsen

Screenshot 2020-10-28 at 10.57.44.png

Technology Oversight

Dr Stuart Ibsen is Assistant Professor of Biomedical Engineering at the School of Medicine, Oregon Health & Science University. His research focuses on early cancer treatment, biomarker screening and bio-sensing


Janette Steele 

PPI Oversight

Janette Steele OBE is principal at Chelsea Community Hospital School and serve on the project advisory board. 

Sue Spencer

Sue .jpg

Regulatory Consultant

Sue Spencer and her colleagues from QServe are medical device and IVD regulatory specialists. Sue was involved in the drafting of the incoming IVDR legislation.

Sebastien Mussalian


Human Factors Design

Sebastien Mussalian is CEO of Pix Medical, an award-winning device development consultancy, with a focus on connected technologies for the healthcare industry


Frederic Irigaray

Digital Content Creator

Frederic Irigaray is a Freelance Creative professional, who specialises in creating film, apps, infographics and website suitable for young audience

Massimo Micocci


Human Factors

Dr Massimo Micocci is a Research Associate in Human Factors at the NIHR London IVD Cooperative with expertise in applying human-centred design methods to evaluate the usability and feasibility of diagnostic tools.   

Samantha Shelley

Sam Shelley 2021 headshot 3 cropped.jpg

Quality Management Consultant

Sam is CEO of SQMS, specialists in medical device quality management. Sam is integral in helping the project establish its ISO 13485 compliant quality management system.

Yann Mamie


Medical Device Engineer

Yann is a Vesynta prototyping engineer supporting the development of the ChromaDose hardware. Yann graduated in 2020 with a MSci in Materials Science and Engineering from EPFL.

Tobias de Mendonca

074 (1)_edited_edited.jpg

Medical Device Engineer

Toby is a Vesynta device engineer with a background as an analytical scientist. Toby graduated from the University of Oxford (2020) with a Master's in Chemistry (MChem). 

bottom of page